These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 842583)
21. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Scott JZ; Kletzky OA; Brenner PF; Mishell DR Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356 [TBL] [Abstract][Full Text] [Related]
22. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma. Spona J; Ulm R; Bieglmayer C; Husslein P Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775 [TBL] [Abstract][Full Text] [Related]
23. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach. Lemay A; Faure N J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711 [TBL] [Abstract][Full Text] [Related]
24. Hyperprolactinemia in cases of infertility and amenorrhea. Furuhjelm M; Rydner T; Carlström K Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290 [TBL] [Abstract][Full Text] [Related]
25. Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization. Wu E; Xiao B; Yan W; Li H; Wu B Contraception; 1992 Jun; 45(6):583-93. PubMed ID: 1617967 [TBL] [Abstract][Full Text] [Related]
27. Pulsatile luteinizing hormone secretion during the first and the fourth cycle on two different oral contraceptives containing gestodene. Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J Acta Endocrinol (Copenh); 1993 Sep; 129(3):229-36. PubMed ID: 8212988 [TBL] [Abstract][Full Text] [Related]
28. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
29. Changes in physiological, EEG and psychological parameters in women during the spontaneous menstrual cycle and following oral contraceptives. Becker D; Creutzfeldt OD; Schwibbe M; Wuttke W Psychoneuroendocrinology; 1982; 7(1):75-90. PubMed ID: 7100370 [TBL] [Abstract][Full Text] [Related]
30. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive. Spellacy WN; Kalra PS; Buhi WC; Birk SA Am J Obstet Gynecol; 1980 May; 137(1):109-15. PubMed ID: 6768295 [TBL] [Abstract][Full Text] [Related]
31. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives. Snowden EU; Khan-Dawood FS; Dawood MY Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin. Tyson JE; Khojandi M; Huth J; Smith B; Thomas P Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151 [TBL] [Abstract][Full Text] [Related]
33. [Blood serum content of prolactin, follicle-stimulating hormone, luteinizing hormone, estradiol and progesterone in women with normal menstrual cycle]. Khamad'ianov UR; Laricheva IP; Smirnova LK Probl Endokrinol (Mosk); 1980; 26(2):32-7. PubMed ID: 6769108 [TBL] [Abstract][Full Text] [Related]
34. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips. Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561 [TBL] [Abstract][Full Text] [Related]
36. Blood hormone levels in egyptian women on norethisterone oenanthate. Saleh FM; Sallam HN; Abdel-Rahman H; Souka AR; El-Sahwi SY; Toppozada HK Contraception; 1983 Jul; 28(1):41-51. PubMed ID: 6414760 [TBL] [Abstract][Full Text] [Related]
37. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment]. Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402 [TBL] [Abstract][Full Text] [Related]
38. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer. Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639 [TBL] [Abstract][Full Text] [Related]
39. Pulsatile luteinizing hormone patterns in long term oral contraceptive users. Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046 [TBL] [Abstract][Full Text] [Related]
40. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle. Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]